Ardens Lifescience wins 2026 MTI Asia Pacific Grand Prize

MedTech Innovator Asia Pacific Names Ardens Lifescience 2026 Grand Prize Winner

LOS ANGELES & SINGAPORE, Oct 27 (Bernama) -- MedTech Innovator (MTI), the world’s largest accelerator of medical device, digital health, and diagnostic companies, today announced Ardens Lifescience as the 2026 MedTech Innovator Asia Pacific Grand Prize Winner, awarding the company USD 175,000 cash prize for its transbronchial radiofrequency (RF) ablation system with a conforming electrode for peripheral lung cancer.

The announcement was made at the MedTech Innovator Asia Pacific Showcase & Grand Finals in Singapore, where four finalists – Ardens Lifescience, BaiYi Healthcare Technology, Eyes of AI, and Physiologas Technology – competed before an audience of industry leaders, investors, healthcare stakeholders and innovators. Following the finalist presentations and a live Q&A with a panel of medtech executives, the audience selected Ardens Lifescience as the 2026 Grand Prize Winner. The three runners-up each received USD 10,000.

For full news, click here